Clinical Trial Update: Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated adding topiramate to whole-body cooling in neonates with hypoxic-ischemic encephalopathy; the study was terminated and results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Kristin R Hoffman | Conditions: Hypoxic Ischemic Encephalopathy | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-06-11